Nursing Care Plan: Warfarin Overdose and INR Management
This nursing care plan examines a 65-year-old male patient with a complex medical history who presents with hematuria and generalized weakness attributable to an excessive Coumadin (warfarin) dose and an out-of-range INR. The paper reviews the patient's assessment data, identifies the critical concern of anticoagulation imbalance and its bleeding risks, and outlines nursing diagnoses, goals, interventions, and evaluation criteria. Key topics include warfarin pharmacology, the importance of regular INR monitoring, drug and food interactions affecting anticoagulation, and strategies for building patient-nurse rapport to support compliance with blood testing protocols.
- Assessment Data and Patient History: Detailed patient history, medications, and support system
- Critical Area of Concern: Abnormal INR and Bleeding Risk: Warfarin bleeding risks and out-of-range INR consequences
- Importance of INR Monitoring and Warfarin Interactions: Regular blood testing and drug-food interaction guidance
- Nursing Diagnosis and Care Plan: Diagnosis of excessive Coumadin dose and treatment goal
- Nursing Interventions and Evaluation: Venipuncture strategy and patient satisfaction evaluation
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper follows a clear clinical structure — assessment, diagnosis, goal, intervention, and evaluation — mirroring real-world nursing care plan format, which makes it easy to follow and credible.
- It grounds abstract pharmacological concepts (warfarin mechanism, INR ranges, bleeding risk) in a specific, richly detailed patient case, keeping the discussion applied rather than theoretical.
- It incorporates peer-reviewed and clinical references to support key claims about warfarin management, giving the paper appropriate academic weight for a health sciences course.
Key academic technique demonstrated
The paper effectively uses a case-based reasoning approach: patient data drives each subsequent clinical decision. Rather than presenting warfarin pharmacology in isolation, the author anchors every claim — about bleeding risk, drug interactions, and monitoring frequency — directly to the patient's presenting symptoms and medication list. This technique demonstrates applied clinical thinking, a core skill in nursing education.
Structure breakdown
The paper is organized into two major sections. The first covers assessment data analysis, including the patient's history, support system, the critical INR concern, and the rationale for monitoring. The second section presents the formal nursing care plan with a diagnosis, goal, intervention strategy, and evaluation criteria. This two-part framework mirrors standard nursing documentation practice and provides a logical, stepwise argument from assessment to action.
Assessment Data and Patient History
The patient is a 65-year-old male, Mexican-born, retired bus driver with a relevant past medical history of atrial fibrillation and deep vein thrombosis (DVT) treated with Coumadin, who presents with hematuria. He sought care after noticing blood in his urine and feeling generally weak. His additional medical history includes hypertension, stroke, DVT, benign prostatic hyperplasia (BPH), gout, depression, anxiety, chronic bronchitis, and a remote history of chickenpox. He has no known drug allergies, and his past surgical history is notable only for an appendectomy.
The patient drinks alcohol (one beer per day), smokes (half a pack per day), and has never used illicit drugs. He reports a family history of hypertension, arthritis, asthma, colon cancer, diabetes, and gastric ulcers. His current prescription medications include: Coumadin (warfarin) 3 mg orally daily; Flomax (tamsulosin) 0.4 mg orally daily; Senna 187 mg orally daily; Metoprolol tartrate 12.5 mg orally daily; Lisinopril 2.5 mg orally twice daily; Finasteride 5 mg orally daily; Docusate sodium 100 mg orally three times daily; Oxycodone 5/325 mg orally every four hours as needed for moderate to severe pain; Remeron 30 mg orally at bedtime; Cardizem 10 mg intravenous push as needed; Allopurinol 300 mg orally daily; Colchicine 0.6 mg orally daily; and Levofloxacin 500 mg orally daily. His over-the-counter medication is acetaminophen 325 mg, two tablets orally every four hours as needed.
The patient's primary strength is a robust support system consisting of three children and a sibling who are available to assist him through his complex and challenging medical situation.
Critical Area of Concern: Abnormal INR and Bleeding Risk
The critical area of concern for this patient is his abnormal International Normalized Ratio (INR). The most significant and common adverse effect of warfarin is hemorrhage. While the risk of severe bleeding is relatively small, it is real and definite; any clinical benefit must clearly outweigh this risk before warfarin is prescribed or continued. The risk of bleeding is substantially increased when the INR falls outside the therapeutic range — whether due to accidental or deliberate overdose or due to drug interactions — and may manifest as hemoptysis (coughing up blood), excessive bruising, bleeding from the nose or gums, or blood in the urine or stool.
The bleeding risk is further elevated when warfarin is combined with antiplatelet drugs such as aspirin or other NSAIDs. Risk is also heightened in elderly patients and in those on hemodialysis. Beyond commonly used medications that interact with warfarin, certain foods — particularly fresh, plant-based foods containing vitamin K — can alter its activity. For this reason, the anticoagulant effect must be regularly monitored through INR blood testing to ensure that the dose is both adequate and safe. A high INR predisposes the patient to a high risk of bleeding, while an INR below the therapeutic target indicates that the warfarin dose is insufficient to protect against thromboembolic events (Ansell et al., 2004).
References
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004). The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3 Suppl), 204S–233S.
Fritsma, G. A. (2002). Evaluation of hemostasis. In B. Rodak (Ed.), Hematology: Clinical principles and applications (pp. 719–753). W.B. Saunders.
Griffiths, J., & Hutchings, W. (1999). The wider implications of an audit of care plan documentation. Journal of Clinical Nursing, 8(1), 57–65.
Holbrook, A. M., Pereira, J. A., Labiris, R., et al. (2005). Systematic overview of warfarin and its drug and food interactions. Archives of Internal Medicine, 165(10), 1095–1106.
Always verify citation format against your institution’s current style guide requirements.